Cargando…
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591738/ https://www.ncbi.nlm.nih.gov/pubmed/33135355 http://dx.doi.org/10.1002/ctm2.214 |
| _version_ | 1783601046956802048 |
|---|---|
| author | He, Zifan Li, Anlin Lin, Dagui Gu, Yang Chen, Yongjian Ou, Qiyun Li, Liren Yao, Herui Yu, Yunfang |
| author_facet | He, Zifan Li, Anlin Lin, Dagui Gu, Yang Chen, Yongjian Ou, Qiyun Li, Liren Yao, Herui Yu, Yunfang |
| author_sort | He, Zifan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7591738 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75917382020-10-30 Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation He, Zifan Li, Anlin Lin, Dagui Gu, Yang Chen, Yongjian Ou, Qiyun Li, Liren Yao, Herui Yu, Yunfang Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-10-27 /pmc/articles/PMC7591738/ /pubmed/33135355 http://dx.doi.org/10.1002/ctm2.214 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor He, Zifan Li, Anlin Lin, Dagui Gu, Yang Chen, Yongjian Ou, Qiyun Li, Liren Yao, Herui Yu, Yunfang Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title | Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title_full | Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title_fullStr | Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title_full_unstemmed | Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title_short | Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation |
| title_sort | association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor t mutation |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591738/ https://www.ncbi.nlm.nih.gov/pubmed/33135355 http://dx.doi.org/10.1002/ctm2.214 |
| work_keys_str_mv | AT hezifan associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT lianlin associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT lindagui associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT guyang associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT chenyongjian associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT ouqiyun associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT liliren associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT yaoherui associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation AT yuyunfang associationofimmunecheckpointinhibitorwithsurvivalinpatientswithcancerswithproteintyrosinephosphatasereceptortmutation |